ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2018

A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.

Todd A Fehniger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.